Discovery and development of Hsp90 inhibitors: a promising pathway for cancer therapy
JR Porter, CC Fritz, KM Depew - Current opinion in chemical biology, 2010 - Elsevier
The Hsp90 chaperone is a master regulator of the stability and activity of multiple
oncoproteins such as Her2, Akt, Bcr-Abl, c-Kit, EGFR and mutant BRAF. The promise of …
oncoproteins such as Her2, Akt, Bcr-Abl, c-Kit, EGFR and mutant BRAF. The promise of …
Discovery and development of Hsp90 inhibitors: a promising pathway for cancer therapy.
JR Porter, CC Fritz, KM Depew - Current Opinion in Chemical …, 2010 - europepmc.org
The Hsp90 chaperone is a master regulator of the stability and activity of multiple
oncoproteins such as Her2, Akt, Bcr-Abl, c-Kit, EGFR and mutant BRAF. The promise of …
oncoproteins such as Her2, Akt, Bcr-Abl, c-Kit, EGFR and mutant BRAF. The promise of …
Discovery and development of Hsp90 inhibitors: a promising pathway for cancer therapy
JR Porter, CC Fritz, KM Depew - Current Opinion in Chemical Biology, 2010 - infona.pl
The Hsp90 chaperone is a master regulator of the stability and activity of multiple
oncoproteins such as Her2, Akt, Bcr-Abl, c-Kit, EGFR and mutant BRAF. The promise of …
oncoproteins such as Her2, Akt, Bcr-Abl, c-Kit, EGFR and mutant BRAF. The promise of …
[引用][C] Discovery and development of Hsp90 inhibitors: a promising pathway for cancer therapy
JR Porter, CC Fritz, KM Depew - Current Opinion in Chemical Biology, 2010 - cir.nii.ac.jp
Discovery and development of Hsp90 inhibitors: a promising pathway for cancer therapy | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Discovery and development of Hsp90 inhibitors: a promising pathway for cancer therapy
JR Porter, CC Fritz, KM Depew - Current opinion in …, 2010 - pubmed.ncbi.nlm.nih.gov
The Hsp90 chaperone is a master regulator of the stability and activity of multiple
oncoproteins such as Her2, Akt, Bcr-Abl, c-Kit, EGFR and mutant BRAF. The promise of …
oncoproteins such as Her2, Akt, Bcr-Abl, c-Kit, EGFR and mutant BRAF. The promise of …